Stockreport
Assessing Incyte (INCY) Valuation As Recent Returns Send Mixed Signals [Yahoo! Finance]
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Incyte (INCY) is back on investors' radar after recent trading, with the share price around US$97.82 and mixed return patterns over the past month and past 3 months prompting closer attention to fundamentals. See our latest analysis for Incyte. The 1 month share price return of 7.75% contrasts with a 3 month share price decline of 4.68%, while the 1 year total shareholder return of 72.22% points to stronger longer term momentum. If Incyte's recent move has you thinking about where else growth stories might be emerging, this is a good moment to scan 37 healthcare AI stocks With revenue and net income both showing annual contraction and the shares trading around US$97.82, the key question is whether Incyte is still trading below its underlying worth or if the market is already pricing in future growth? Most Popular Narrative: 2.3% Undervalued Incyte's most followed narrative pegs fair value around $100.10, slightly above the recent $97.82 close. This frames the current move
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INCY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INCY alerts
INCY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
NEWS
NEWS
- RBC Capital Lifts PT on Incyte Corporation (INCY) to $95 From $92 [Yahoo! Finance][Yahoo! Finance]
- Incyte (INCY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $135.00 price target on the stock.[MarketBeat]
- Incyte to Report First Quarter Financial Results[Business Wire]
- Incyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology Collaboration - Has The Bull Case Changed? [Yahoo! Finance][Yahoo! Finance]
- Incyte (INCY) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c+)" to "buy (b-)".[MarketBeat]
- More
INCY
SEC Filings
SEC Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- INCY's page on the SEC website
- More